Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme
Copyright © 2015 Elsevier B.V. All rights reserved..
All known gammaherpesviruses encode at least one conserved tegument protein that contains sequence homology to the cellular purine biosynthesis enzyme: phosphoribosylformylglycineamide amidotransferase (FGARAT, or PFAS). While no enzymatic activity have been found on these viral FGARAT-homology proteins (vFGARAT), they are important for disarming host intrinsic antiviral machinery. Most vFGARAT proteins disrupt the intrinsic antiviral response-associated cellular subnuclear structure: ProMyelocytic Leukemia (PML) associated nuclear body (PML-NB). vFGARATs from different viruses target different components of PML-NB to prevent cellular repression of viral infection. In addition, vFGARATs of rhadinoviruses were recently found to oligomerize with the cellular FGARAT to deamidate RIG-I and repress inflammatory cytokine production. In this review we discuss the diverse mechanisms of antiviral response disruption by gammaherpesvirus vFGARATs and the significance of the enzyme homology domain.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Current opinion in virology - 14(2015) vom: 15. Okt., Seite 30-40 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tsai, Kevin [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 2.1.2.2 |
---|
Anmerkungen: |
Date Completed 02.08.2016 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.coviro.2015.07.008 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM251665526 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM251665526 | ||
003 | DE-627 | ||
005 | 20231226192133.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.coviro.2015.07.008 |2 doi | |
028 | 5 | 2 | |a pubmed24n0838.xml |
035 | |a (DE-627)NLM251665526 | ||
035 | |a (NLM)26256000 | ||
035 | |a (PII)S1879-6257(15)00106-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tsai, Kevin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.08.2016 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2015 Elsevier B.V. All rights reserved. | ||
520 | |a All known gammaherpesviruses encode at least one conserved tegument protein that contains sequence homology to the cellular purine biosynthesis enzyme: phosphoribosylformylglycineamide amidotransferase (FGARAT, or PFAS). While no enzymatic activity have been found on these viral FGARAT-homology proteins (vFGARAT), they are important for disarming host intrinsic antiviral machinery. Most vFGARAT proteins disrupt the intrinsic antiviral response-associated cellular subnuclear structure: ProMyelocytic Leukemia (PML) associated nuclear body (PML-NB). vFGARATs from different viruses target different components of PML-NB to prevent cellular repression of viral infection. In addition, vFGARATs of rhadinoviruses were recently found to oligomerize with the cellular FGARAT to deamidate RIG-I and repress inflammatory cytokine production. In this review we discuss the diverse mechanisms of antiviral response disruption by gammaherpesvirus vFGARATs and the significance of the enzyme homology domain | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Review | |
650 | 7 | |a Viral Structural Proteins |2 NLM | |
650 | 7 | |a Phosphoribosylglycinamide Formyltransferase |2 NLM | |
650 | 7 | |a EC 2.1.2.2 |2 NLM | |
700 | 1 | |a Messick, Troy E |e verfasserin |4 aut | |
700 | 1 | |a Lieberman, Paul M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current opinion in virology |d 2011 |g 14(2015) vom: 15. Okt., Seite 30-40 |w (DE-627)NLM216114179 |x 1879-6265 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2015 |g day:15 |g month:10 |g pages:30-40 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.coviro.2015.07.008 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2015 |b 15 |c 10 |h 30-40 |